Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer:: association with disease progression
Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer:: association with disease progression
复制标题
DOI：
10.1016/s0959-8049(02)00502-6
复制
发表时间：
2003-03-01
影响因子：
8.4
通讯作者：
Nikolic-Vukosavljevic, D
中科院分区：
文献类型：
--
作者：
Ivanovic, V;Todorovic-Rakovic, N;Nikolic-Vukosavljevic, D
我们研究了血浆TGF-β 1水平升高与晚期乳腺癌（BC）患者（n = 44）疾病进展之间的关系。通过酶联免疫吸附试验（ELISA）检测TGF-β（1）水平。对我们的血浆样本中的血小板残留和体外血小板活化进行了评估，发现无显著性。血浆TGF-β（1）值显著升高（P
We examined the association between an elevated plasma TGF-beta(1) level and the disease progression of advanced breast cancer (BC) patients (n = 44). TGF-beta(1) levels were detected by an enzyme-linked immunosorbent assay (ELISA). Platelet carryover and in vitro platelet activation in our plasma samples was assessed and found to be insignificant. Plasma TGF-beta(1) values were significantly elevated (P